Stock Movers Pets at Home Up, Valneva Up, WPP Down
Nov 26, 2025
Pets at Home sees a 6.8% rise after announcing a promising retail turnaround plan, delighting analysts. Meanwhile, Valneva shares impressive results for its Lyme disease vaccine, buoying hopes for future success. In contrast, WPP faces a downturn, with expectations of being removed from the FTSE 100 amid challenges like AI competition. On a brighter note, British Land is set to join the index, signaling a positive shift in the sector.
AI Snips
Chapters
Transcript
Episode notes
Pets At Home Stabilizing After Covid Boom
- Pets at Home met lowered estimates despite weak retail profit, signaling stabilization after a post-Covid slowdown.
- Analysts noted improving retail trends, which encouraged the share rise on hopes of a retail turnaround.
Promising Lyme Vaccine Data Spurs Momentum
- Valneva reported positive Phase 2 immunogenicity and safety data for a Lyme vaccine, boosting shares on promising results.
- Analysts called the upcoming late-stage readout a high-impact catalyst, with potential for annual protection if trials succeed.
WPP Loses FTSE 100 Spot Amid Structural Pressure
- WPP faces multi-year headwinds from AI, reduced client spend and tougher competition, crushing its share price this year.
- The firm is indicated to be removed from the FTSE 100, to be replaced by British Land after the quarterly index review.